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Protein phosphatase 2A regulates MPF activity and sister
chromatid cohesion in budding yeast
Jeremy Minshull*†, Aaron Straight‡, Adam D. Rudner‡, Abby F. Dernburg‡§, 
Andrew Belmont¶ and Andrew W. Murray*‡
Background: Mitosis is regulated by MPF (maturation promoting factor), the
active form of Cdc2/28–cyclin B complexes. Increasing levels of cyclin B
abundance and the loss of inhibitory phosphates from Cdc2/28 drives cells into
mitosis, whereas cyclin B destruction inactivates MPF and drives cells out of
mitosis. Cells with defective spindles are arrested in mitosis by the spindle-
assembly checkpoint, which prevents the destruction of mitotic cyclins and the
inactivation of MPF. We have investigated the relationship between the spindle-
assembly checkpoint, cyclin destruction, inhibitory phosphorylation of Cdc2/28,
and exit from mitosis.
Results: The previously characterized budding yeast mad mutants lack the
spindle-assembly checkpoint. Spindle depolymerization does not arrest them in
mitosis because they cannot stabilize cyclin B. In contrast, a newly isolated
mutant in the budding yeast CDC55 gene, which encodes a protein
phosphatase 2A (PP2A) regulatory subunit, shows a different checkpoint defect.
In the presence of a defective spindle, these cells separate their sister
chromatids and leave mitosis without inducing cyclin B destruction. Despite the
persistence of B-type cyclins, cdc55 mutant cells inactivate MPF. Two
experiments show that this inactivation is due to inhibitory phosphorylation on
Cdc28: phosphotyrosine accumulates on Cdc28 in cdc55D cells whose
spindles have been depolymerized, and a cdc28 mutant that lacks inhibitory
phosphorylation sites on Cdc28 allows spindle defects to arrest cdc55 mutants
in mitosis with active MPF and unseparated sister chromatids. 
Conclusions: We conclude that perturbations of protein phosphatase activity
allow MPF to be inactivated by inhibitory phosphorylation instead of by cyclin
destruction. Under these conditions, sister chromatid separation appears to be
regulated by MPF activity rather than by protein degradation. We discuss the
role of PP2A and Cdc28 phosphorylation in cell-cycle control, and the possibility
that the novel mitotic exit pathway plays a role in adaptation to prolonged
activation of the spindle-assembly checkpoint.
Background
Cell-cycle checkpoints coordinate the cell cycle by
making one step dependent upon the successful comple-
tion of previous steps (reviewed in [1–3]). Faithful trans-
mission of genetic information depends on accurate
chromosome segregation, which in turn requires a micro-
tubule structure known as the mitotic spindle. Sister kine-
tochores in a replicated pair of sister chromatids are
attached to opposite poles of the bipolar spindle, so that
when they separate they are drawn apart, ensuring that
each daughter cell receives one copy of each chromosome.
The spindle-assembly checkpoint contributes to the accu-
racy of mitosis by delaying the onset of anaphase until the
spindle has been fully assembled and each pair of sister
chromatids is attached to it. Exit from mitosis depends on
the proteolysis of cyclin B [4], and sister separation
appears to require the destruction of other proteins [5–7];
the destruction of both sets of proteins requires a specific
set of ubiquitinating enzymes [8–10]. Cyclin B destruction
leads to the inactivation of MPF (maturation promoting
factor or M-phase promoting factor), the Cdc2/28–cyclin B
complex, whose activity is measured experimentally as
histone H1 kinase [11] (Cdc28 is the budding yeast
homolog of the fission yeast Cdc2 protein). 
Our current understanding of the spindle-assembly check-
point comes from a variety of approaches. Experimental
manipulations of insect spermatocytes and vertebrate
tissue culture cells suggest that kinetochores that have not
attached to the spindle act to delay anaphase [12–14], and
have identified a kinetochore-associated phosphoepitope
found only on those chromosomes that are improperly
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aligned on the spindle [15,16]. Biochemical analysis shows
that preventing spindle assembly in Xenopus egg extracts
blocks cyclin B degradation and MPF inactivation, mimic-
king the mitotic arrest seen in nocodazole-treated tissue
culture cells [17]. The MAP kinase ERK2 is required for
proper functioning of the frog checkpoint, but neither the
signal being detected, nor the mechanism by which cyclin
degradation is blocked are known [17]. 
Genetic analysis of budding yeast has identified multiple
genes involved in the spindle assembly checkpoint
(MAD1–3, BUB1–3 and MPS1) [18–23]. Most of these
genes were identified by mutations that allow cells to pass
through mitosis without a fully assembled mitotic spindle.
In the presence of a defective spindle assembly check-
point, mutants fail to sustain MPF activity, allowing them
to pass through mitosis and into the next cell cycle with
lethal consequences [18,19]. Components of the spindle-
assembly checkpoint are conserved between budding
yeast, fission yeast, frogs and mammals [23–25]. 
Here, we show that budding yeast cdc55 mutants define a
novel class of spindle assembly checkpoint mutants.
CDC55 encodes a protein homologous to the B regulatory
subunit of a type 2A protein phosphatase (PP2A) [26,27].
Comparing cdc55 cells with the mad mutants reveals a
novel pathway for exit from mitosis. In mad1, mad2 and
mad3 mutants, spindle disruption fails to protect B-type
cyclins from degradation. In contrast, cdc55 cells do not
degrade B-type cyclins, although they still inactivate MPF
and separate their sister chromatids. Replacement of
inhibitory phosphorylation sites in Cdc28 with nonphos-
phorylatable residues allows cdc55 cells that lack spindles
to sustain their MPF levels and prevent sister chromatid
separation. We discuss these results with regard to the role
of PP2A in cell-cycle regulation, mechanisms of escaping
from mitotic arrest, and the roles of proteolysis and phos-
phorylation in sister chromatid cohesion.
Results
cdc55 mutants lack a functional spindle assembly
checkpoint
Because the original screens for mitotic checkpoint
mutants in budding yeast were not saturating [18,19], we
performed another screen for mutants that were hypersen-
sitive to the microtubule-depolymerizing drugs benomyl
and nocodazole. We used similar criteria to those already
described [19] to isolate putative spindle-assembly check-
point mutants: hypersensitivity to benomyl and nocoda-
zole, and re-budding accompanied by rapid loss of cell
viability when exposed to concentrations of these drugs
that arrest wild-type cells in mitosis.
One recessive mutant that passed all of these tests, desig-
nated JM215, was cloned by complementation using a
genomic DNA library. Figure 1 shows a map of the rescu-
ing clone. Sequencing the ends of the clone allowed us to
identify the genomic DNA fragment as one containing
two open reading frames: the CDC55 gene, which encodes
a yeast homologue of the B subunit of a PP2A [26]; and a
sequence encoding an unidentified 147 amino-acid
polypeptide. We constructed a deletion plasmid that
removed the promoter and amino-terminal 280 codons of
CDC55 but not the second open reading frame, replacing
them with the HIS3 marker (Fig. 1). Integration of this
plasmid at the genomic locus resulted in a strain (cdc55D)
with the same spindle-assembly checkpoint defects as
JM215: increased sensitivity to benomyl on plates (Fig.
2a), and rapid death in liquid media containing 10 mg ml–1
nocodazole (Fig. 2b). As with other mad mutants, this
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Figure 1
Restriction map of the 2.8 kb SacI–Mlu1
Saccharomyces cerevisiae genomic DNA
fragment that rescued the benomyl sensitivity
and sporulation defect of JM215. The ends
(300 bp) of the fragment were sequenced and
compared with sequences in the Genbank
database. This identified the DNA as a
2830 bp segment containing CDC55 and an
unidentified open reading frame. A CDC55
deletion construct was made by inserting the
HIS3 gene between the SpeI and BamHI
sites as indicated.
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nocodazole sensitivity was rescued by the inclusion of
10 mg ml–1 of the DNA synthesis inhibitor hydroxyurea
(Fig. 2b, [19]). Diploids formed by crossing cdc55D with
strains carrying the mutation present in JM215 failed to
sporulate unless they contained a plasmid carrying the
wild-type CDC55 gene. All the spores dissected from such
diploids and then cured of the CDC55 plasmid displayed
the phenotypes of JM215, demonstrating that this mutant
contains a loss-of-function mutation in CDC55, designated
cdc55-215. All subsequent experiments were conducted on
the deletion strain.
Clb proteins are stable in cdc55 mutants but MPF is
inactivated
Of the six previously reported spindle-assembly checkpoint
genes, BUB1, BUB2 and MAD2 have been shown to be
required to sustain MPF activity when spindle micro-
tubules are depolymerized [18,19]. MPF is normally inacti-
vated at the end of mitosis by cyclin B proteolysis, and
preventing this destruction prevents exit from mitosis
[4,28]. We therefore wondered if the failure of mad mutants
to arrest in mitosis resulted from their inability to prevent
cyclin proteolysis. We looked at the levels of the yeast
mitotic cyclins, Clb2 and Clb3 [29,30], in cells synchro-
nously released from an a factor (G1-phase) block into
medium containing 10 mg ml–1 nocodazole, a concentration
that activates the spindle-assembly checkpoint in wild-type
cells. Figure 3a shows that, in wild-type cells, nocodazole
treatment stabilizes Clb2 and Clb3, leading to high levels of
histone H1 kinase activity in Clb-associated Cdc28 (Fig.
3b). In contrast, mad2 cells failed to prevent degradation of
Clb2 and Clb3, and as a result the Clb-associated histone
H1 kinase levels fell. We saw a similar fall of Clb protein
levels and kinase activities in other spindle-assembly
checkpoint mutants (mad1, mad3 and bub1; data not shown).
The behavior of the mitotic cyclins in cdc55D cells differed
from both wild-type and other spindle-assembly check-
point mutants. Clb2 appeared stable in cdc55D cells
released from a G1 arrest into nocodazole (Fig. 3a), but
although histone H1 kinase activity initially rose (a little
slower than in wild-type cells, probably resulting from its
longer doubling time), the mutant was unable to sustain
high kinase levels (Fig. 3b). Histone H1 kinase activity of
Clb2 immunoprecipitates containing equivalent amounts
of Cdc28 (as judged by western blotting with anti-
PSTAIRE antibodies) was 3–5-fold lower in nocodazole-
treated cdc55D cells than in wild-type cells.
Loss of MPF activity correlates with sister chromatid
separation
If sister chromatids separate before they have attached to
the spindle, they will presumably segregate randomly with
respect to each other. Thus, to prevent the generation of
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Figure 2
Benomyl sensitivity of JM215, mad2D and
cdc55D. (a) Yeast were grown in YPD
overnight, diluted to A600 1.0 and four serial
10-fold dilutions were replicated onto YPD
plates containing no additions (left) or
7.5 mg ml–1 benomyl (right). The plates were
incubated at 23 °C for 2 days. (b) Yeast were
grown overnight in YPD to mid-log phase,
then diluted to A600 0.3 in YPD containing
10 mg ml–1 nocodazole ± 10 mg ml–1
hydroxyurea. Samples were withdrawn at
90 min intervals, diluted 5000-fold, and
200 ml was spread onto a YPD plate which
was incubated at 23 °C for 3 days. The
number of colonies was compared with the
number immediately before nocodazole
addition to determine the percent remaining
viable.
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aneuploidy, the spindle assembly checkpoint should
prevent sister separation as well as the inactivation of
MPF. We therefore investigated whether sister separation
occurred in mutants that inactivated the spindle assembly
checkpoint.
We used two assays to monitor sister chromatid linkage.
The first was a modification of existing in situ hybridiza-
tion protocols [31,32] that allowed the ribosomal DNA
(rDNA) locus on chromosome XII to be localized in cells
that had not been subjected to proteolysis [33]. The
second was a novel technique based on the binding of a
fusion protein, GFP–LacI (green fluorescent protein
fused to the Lac repressor), to a 10 kb array consisting of
256 tandem repeats of the Lac operator (LacO) integrated
into chromosome III [34]. 
Figure 4 shows chromosomes in nocodazole-treated wild-
type and cdc55D cells visualized either by in situ hybridiza-
tion or by induction of the GFP–LacI fusion. In both
cases, a single signal was seen in wild-type cells and two
separate signals were seen in cdc55D cells, indicating that
an intact spindle-assembly checkpoint is required to main-
tain sister chromatid linkage in cells whose spindles have
been depolymerized. The two sister separation assays
gave quantitatively very similar results (data not shown).
We used the LacO-tagged chromosome to compare the
effects of the two different classes of spindle-assembly
checkpoint mutant on sister chromatid separation in cells
whose spindle had been depolymerized by nocodazole
treatment. Figure 5 shows that less than 5 % of wild-type
cells arrested in nocodazole had two fluorescent spots in
their nuclei, indicating that sister chromatids had not sepa-
rated by more than the resolution limit of the light micro-
scope (0.2 mm). In both mad2D and cdc55D cells, however,
a dramatic increase in the fraction of nuclei containing two
spots coincided with the drop in MPF activity, showing
that defects in the spindle-assembly checkpoint allow
both MPF inactivation and sister separation in cells that
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Figure 3
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Clb2 protein and associated kinase levels in wild-type, mad2D,
cdc55D and cdc55D, Cdc28-VF cells. (a) The four yeast strains were
grown overnight in YPD to mid-log phase, then diluted to A600 0.3 in
YPD containing 10 mg ml–1 a factor. Cells were arrested for 150 min,
then washed into YPD containing 10 mg ml–1 nocodazole. a factor was
added back to the cultures 90 min after the nocodazole to prevent
reaccumulation of Clb2 in cells that had exited from mitosis. Samples
were taken at 30 min intervals, lysed and immunoblotted for Clb2 and
Clb3 proteins. This experiment was repeated five times with similar
results. (b) Clb2 was immunoprecipitated from samples of the lysates
prepared in (a). The immunoprecipitates were tested for their ability to
phosphorylate histone H1. The kinase reactions were run on a 15 %
polyacrylamide gel and radiolabeled phosphate incorporation was
measured using a Molecular Dynamics Phosphorimager.
lack spindles. In the mad2D mutant, sister separation also
coincided with Clb2 proteolysis, but there was no such pro-
teolysis seen in cdc55D cells (compare Fig. 3a,b with Fig. 5).
To confirm that the GFP–LacI signal was indeed measur-
ing sister chromatid separation, we also used in situ
hybridization to assess the degree of sister chromatid associ-
ation (data not shown). The two methods gave quantita-
tively similar results and both showed that the fraction of
nuclei containing separated sister chromatids in nocoda-
zole-treated mad2D or cdc55D cells never exceeded
50–60 %. Nuclei with a single spot could reflect either the
lack of sister chromatid separation in a fraction of the nuclei,
or the presence of nuclei in which the marked sisters had
separated but could not be resolved by light microscopy.
Cdc28-VF prevents MPF inactivation and sister chromatid
separation
How is MPF inactivated in the absence of cyclin proteoly-
sis in cdc55D cells? We failed to detect dissociation of
Cdc28 from Clb2, or the presence of non-covalently bound
Cdc28 inhibitors in cdc55D cells (data not shown). In
fission yeast and vertebrate cells, the kinase activity of
p34cdc2 (the Cdc28 homolog) is inhibited during G2 by
phosphorylation of threonine and tyrosine (Thr14 and
Tyr15) residues [35–38] in the ATP-binding site of the
enzyme [39]. The homologous residues in Cdc28 are
Thr18 and Tyr19, and phosphorylation of Tyr19 has been
shown to inhibit Cdc28 H1 kinase activity in Saccharomyces
cerevisiae [40]. To test whether cdc55D cells inactivate MPF
by inducing inhibitory phosphorylations on Cdc28, we
made a cdc55D strain containing a mutant cdc28 gene in
which Thr18 was changed to Val18 and Tyr19 to Phe19
(cdc28-VF) [40]. Figure 3b shows that the H1 kinase activ-
ity of Clb2 immunoprecipitates prepared from nocodazole-
treated cultures of the cdc55D cdc28-VF double mutant
strain was sustained rather than falling as it did in cdc55D.
Thus, cdc55D mutants are able to prevent Clb degradation
in response to nocodazole, but inactivate Cdc28-associated
H1 kinase activity of MPF through a pathway that requires
the presence of phosphorylatable residues at Thr18 and
Tyr19. By contrast, in mad1 and mad2 mutants, replace-
ment of the normal CDC28 gene by cdc28-VF failed to
prevent the loss of Clb-associated H1 kinase activity in
nocodazole-treated cells (data not shown), demonstrating
that the primary defect in these mutants is the inability of
spindle defects to prevent activation of the cyclin proteoly-
sis machinery. Although the cdc55D cdc28-VF double
mutant arrests in mitosis when treated with nocodazole,
the cells still die. We do not know whether this lethality is
due to the role of Cdc55 in the spindle-assembly check-
point or to its involvement in other processes such as cell-
wall formation and morphogenesis [26].
Examination of sister chromatid separation in nocodazole-
treated cdc55D cdc28-VF cells revealed that, in addition to
preventing a loss of MPF activity, the non-phosphorylat-
able residues in Cdc28 also prevented sister chromatid
separation (Fig. 5). cdc55D cells in which Cdc28 was
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Figure 4
Visualizing sister chromatid separation in (a,c)
wild-type and (b,d) cdc55D cells treated with
nocodazole by (a,b) in situ hybridization or
(c,d) with a GFP–LacI fusion protein. The in
situ hybridization images were prepared with a
probe to the ribosomal DNA. The GFP images
were prepared from strains with a Lac
operator near the centromere of chromosome
III and which expressed a GFP–Lac repressor
fusion. Note that sister chromatids are still
linked in wild-type cells, but have separated in
cdc55D cells.
mutated at only Thr18 or Tyr19 had intermediate pheno-
types: MPF activity fell and sister chromatids separated,
but more slowly and to a lesser extent than in cdc55D cells
with wild-type Cdc28 (data not shown). 
Cdc28 is tyrosine-phosphorylated in cdc55D cells treated
with nocodazole
The results described above suggest that cdc55D cells
treated with nocodazole escape from mitosis by phospho-
rylating Cdc28 on sites that inhibit its protein kinase
activity. To test this idea directly, we used western blot-
ting with anti-phosphotyrosine antibodies to assay the
tyrosine phosphorylation of Cdc28 in exponentially
growing and nocodazole-treated cells. Figure 6 shows that
asynchronous or nocodazole-treated wild-type cells had
very little phosphotyrosine in Cdc28. By contrast, Cdc28
from nocodazole-treated or asynchronous cdc55D cells
contained easily detectable phosphotyrosine. As
expected, nocodazole-treated cdc55D cells whose wild-
type CDC28 gene had been replaced by the cdc28-VF gene
had no detectable phosphotyrosine on Cdc28. We con-
clude that the mechanism of MPF inactivation in nocoda-
zole-treated cdc55D cells is inhibitory phosphorylation of
Cdc28. The observation that no phosphotyrosine is seen
on Cdc28 in a factor-treated cells is consistent with the
inability of Wee1 to phosphorylate Cdc2 that is not com-
plexed with cyclin B [41].
Cytoplasmic PP2A activity is unaltered in mitotically
arrested cells lacking Cdc55
As Cdc55 is homologous to the mammalian B-regulatory
subunit of PP2A [26], we wished to know whether PP2A
activity differed between wild-type and cdc55D cells. Using
MPF-phosphorylated histone H1 as a substrate [42], we
measured the PP2A activity of yeast cell lysates as the
protein phosphatase activity that was insensitive to
inhibitors of protein phosphatase I but was sensitive to
okadaic acid, a potent inhibitor of PP2A [27,42,43]. As
shown in Figure 7, we could detect only a small difference
between PP2A activity in nocodazole-treated wild-type and
cdc55D cells. We wondered if the lack of difference could be
because wild-type cells were arrested in mitosis, whereas
the cdc55D mutants were not, but we saw no change in
PP2A activity in cdc55D cells 150–240 minutes after addi-
tion of nocodazole, during which time H1 kinase activity
was reduced 4-fold (Fig. 3b and data not shown). We con-
clude that the bulk cytoplasmic levels of PP2A are indistin-
guishable in wild-type and cdc55D cells, consistent with
previous observations using lysates from asynchronous
wild-type and cdc55D cultures [27].
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Figure 5
Sister chromatid separation in spindle-
assembly checkpoint mutants. Four yeast
strains were grown overnight in YPD to mid-
log phase, then diluted to A600 0.3 in YPD
containing 10 mg ml–1 a factor. Cells were
arrested for 120 min, then washed into
complete minimal media lacking histidine and
containing 10 mg ml–1 a factor and 10 mM
aminotriazole to induce expression of
LacI–GFP. After a further 30 min, cells were
washed into media containing 10 mg ml–1
nocodazole. a factor was added 90 min after
the nocodazole to prevent reaccumulation of
Clbs in cells that had exited from mitosis.
Duplicate samples were taken at 30 min
intervals. One set was lysed, Clb2
immunoprecipitated from the samples and
immunoprecipitates tested for their ability to
phosphorylate histone H1. The other set was
washed, fixed and scored for the presence of
one or two GFP-staining spots in the yeast
nucleus. The data shown in this figure comes
from the same experiment shown in Fig. 3.
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Discussion
In this paper, we have shown that Cdc55, a homolog of a
PP2A regulatory subunit, is required for proper function-
ing of the spindle-assembly checkpoint. Unlike the Mad1,
Mad2 and Mad3 proteins, Cdc55 is not involved in regu-
lating the stability of B-type cyclins. Nocodazole-treated
cdc55D cells contain high levels of Cdc28-associated Clb2,
but these complexes have little protein kinase activity.
The Cdc28 protein in these cells is tyrosine phosphory-
lated to a much higher level than the Cdc28 in wild-type
cells treated with nocodazole. MPF remains active and
sister chromatids remain linked in nocodazole-treated
cdc55D mutants if amino acids Thr18 and Tyr19 of Cdc28
are mutated to non-phosphorylatable analogs, demonstrat-
ing that the absence of Cdc55 leads to MPF inactivation
via inhibitory phosphorylation of Cdc28. 
The homologs of Thr18 and Tyr 19 (Thr14 and Tyr15) are
located within the ATP-binding site of Cdk2 [39], and
phosphorylation of these sites been shown to inhibit
kinase activity [40,44]. Inhibitory phosphorylation in the
ATP-binding site of p34cdc2 (the Cdc28 homolog in other
eukaryotes) has been implicated in the checkpoint that
prevents premature MPF activation in both fission yeast
and frogs ([37,38,45], but see also [46]). Studies in
budding yeast, however, have shown that mutation of
amino acids Thr18 and Tyr19 does not affect the ability of
DNA synthesis inhibitors to arrest the cell cycle [47,48].
Phosphorylation of Cdc28 is involved in a checkpoint that
inhibits passage through mitosis in cells that have not
budded, and which may be analogous to the G2/M transi-
tion in other eukaryotes [49]. Here, we have shown that,
as well as preventing entry into mitosis, phosphorylation
of Thr18 and Tyr19 can cause a mitotic cell to progress to
interphase when cyclin proteolysis has been prevented by
the spindle-assembly checkpoint. Thus, the same set of
modifications can both prevent entry into mitosis and
induce exit from mitosis.
Sister chromatids separate when MPF activity falls
We have shown that budding yeast mutants with defects
in the spindle-assembly checkpoint separate their sister
chromatids despite their failure to assemble a spindle.
Cells lacking the MAD2 gene separate their sisters at
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Figure 6
Tyrosine phosphorylation of Cdc28 in cdc55D
mutants. Extracts of the indicated strains
growing asynchronously or treated for 2.5 h
with 10 mg ml–1 of a factor or 15 mg ml–1 of
nocodazole were analyzed for tyrosine
phosphorylation of Cdc28. All strains carried
hemagglutinin (HA)-tagged Cdc28, which
was immunoprecipitated with an anti-HA
antibody (12CA5). The immunoprecipitates
were western blotted with an anti-
phosphotyrosine antibody, before stripping
the blots and reprobing them with the anti-HA
antibody (16B12) as a control for equal
loading. 
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Figure 7
Phosphatase 2A activity in wild-type and cdc55D cells. Wild-type and
cdc55D cells were released from a factor into nocodazole for 150 min.
Lysates were prepared and assayed for phosphatase activity (see
Materials and methods). Both samples were incubated in the presence
of inhibitor I2 to inhibit phosphatase 1 activity. The samples in the open
bars contained no other inhibitor, whereas those in the dark grey bars
also contained okadaic acid, an inhibitor of protein phosphatase 2A
(PP2A). The light gray bars represent the difference between the
activities measured in the presence and absence of okadaic acid. We
attribute this difference to PP2A activity. Duplicate samples were taken
at 0, 15 and 30 min, during which time inorganic phosphate release
(measured as described in [42]) was linear, and less than 10 % of the
substrate was dephosphorylated. The bars indicate half of the range
between the duplicate measurements.
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about the same time that they degrade the Clb2 B-type
cyclins. The destruction of the mitotic cyclins is mediated
by a cyclin-ubiquitinating complex that contains the
Cdc16, Cdc23 and Cdc27 proteins [8–10]. Experimental
modifications of cyclin structure or expression that
prevent MPF inactivation do not prevent sister separation,
as long as the cyclin-proteolysis machinery remains active
[5,50]. These observations have suggested that non-cyclin
proteins must be degraded to allow sister separation, and
recent experiments in fission yeast show that Cut2
destruction by the cyclin proteolysis machinery is required
for sister separation [6]. We were therefore surprised to
find that nocodazole-treated cdc55D cells also separate
their sisters as MPF levels fall, despite the lack of signifi-
cant Clb proteolysis. Furthermore, a strain that was both
cdc55D and contained Cdc28-VF was not only able to
sustain MPF activity when treated with nocodazole, but
also maintained sister chromatid cohesion.
Although we observed no significant cyclin proteolysis in
cdc55D cells, we have not been able to show conclusively
that exit from mitosis can occur in the absence of the cyclin-
proteolysis machinery. A simple test of this hypothesis
would be to combine cdc55D with a mutant, such as cdc16,
cdc23 or cdc27, which inactivates the cyclin proteolysis
machinery [9,10,51,52]. Unfortunately, these latter muta-
tions produce a large increase in the Clb concentrations at
the non-permissive temperature (data not shown). As a
result, in double mutants, the 3–5-fold decrease in Cdc28-
associated kinase induced by removal of Cdc55 does not
reduce MPF activity below that of wild-type mitotic cells.
Until a rigorous test of the role of the cyclin-proteolysis
machinery can be performed, there are three hypotheses
that can account for sister separation in nocodazole-treated
cdc55D cells. In the first model, proteolysis is required for
separation, but cells regulate access of substrates to the
cyclin-proteolysis machinery, thus allowing mitotic cyclins
to remain stable, while proteins that prevent sister separa-
tion, such as Cut2 [6] are destroyed. In this model,
however, it is unclear why the cdc28-VF mutant should
prevent sister separation in nocodazole-treated cdc55D
cells. In the second model, the phosphorylation of chromo-
somal proteins by chromosome-associated MPF maintains
sister cohesion until MPF inactivation induces anaphase.
Manipulations that prevent the overall level of cyclin from
falling allow sisters to separate because they do not prevent
the local inactivation of MPF on the chromosome. In this
model, however, it is unclear why the overproduction of
wild-type Clb2 in budding yeast (the sole mitotic cyclin
required for viability) should disrupt putative chromo-
some-associated MPF and lead to sister separation.
In the third model, either MPF inactivation or activation of
the cyclin-proteolysis machinery can induce sister sep-
aration (Fig. 8). Entry into mitosis would induce activities
that could cause sister separation, but these activities would
be kept in check by regulatory molecules until the onset of
anaphase. If these inhibitors of separation were only active
when they carried MPF-induced phosphorylations, and
were substrates for the cyclin proteolysis machinery, either
MPF activation or activation of the cyclin proteolysis
machinery would induce anaphase (Fig. 8). Thus, in
unusual situations, like that of nocodazole-treated cdc55D
cells, inactivation of MPF without cyclin proteolysis would
induce sister separation. Pds1 in budding yeast and Cut2 in
fission yeast are candidates for proteins that act during
metaphase to inhibit sister separation: deletion of Pds1
allows sister separation in cells arrested in mitosis by the
spindle-assembly checkpoint or defects in the cyclin prote-
olysis machinery [7], and preventing Cut2 destruction at
the onset of anaphase prevents sister separation [6].
The role of PP2A in mitosis 
We believe that the failure of the spindle-assembly check-
point resulting from deletion of the CDC55 gene is proba-
bly caused by inappropriate regulation of PP2A. Cdc55 is
homologous to the PP2A regulatory subunit B from mam-
malian cells [26], and Cdc55 is one component of the
budding yeast PP2A-like phosphatase that is activated in
response to ceramide [27]. We found little difference
between PP2A activities in cytoplasmic extracts made from
wild-type and cdc55D cells, as measured by activity against
MPF-phosphorylated histone H1. Our results are compara-
ble with previous studies in which no difference was found
in the abilities of asynchronous wild-type and cdc55D yeast
extracts to dephosphorylate phosphohistone H1 [27]. 
Interpreting the results of these experiments is made diffi-
cult by the complex regulation of PP2A. Regulatory sub-
units of PP2A can either stimulate or inhibit the
phosphatase activity of catalytic subunits, depending on
the substrate [42,53–55]. Experiments using purified verte-
brate PP2A show that phosphatase activities against CDK-
phosphorylated histone H1, caldesmon and HMG-I(Y) are
greatly decreased in the absence of regulatory subunits
[42]. We have, so far, only been able to measure the phos-
phatase activities of crude yeast lysates rather than purified
phosphatases. In addition, a number of PP2A catalytic sub-
units have been identified in budding yeast (Pph21,
Pph22, Pph3 and the considerably more distantly related
Sit4). To allow us to assay the activity of the purified phos-
phatase from yeast, we are currently trying to determine
which proteins interact with Cdc55 in its role in maintain-
ing the spindle-assembly checkpoint. Possibilities include
the PP2A catalytic subunits as well as Tpd3 (a homolog of
the regulatory A subunit of PP2A). Tpd3 and Sit4 have
been implicated with Cdc55 as components of a ceramide-
induced PP2A activity [27].
A Cdc55-regulated phosphatase could regulate the spindle-
assembly checkpoint by controlling the kinases and
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phosphatases that modulate Cdc28 activity. The inhibitory
tyrosine residue on Cdc28 is phosphorylated by Swe1 and
dephosphorylated by Mih1 (homologs of the fission yeast
Wee1 and Cdc25 proteins, respectively). In vitro evidence
suggests that the vertebrate homologs of these proteins
may be regulated by PP2A [56,57]. In fission yeast and
frogs, PP2A has been shown to prevent MPF activation in
interphase cells and to stimulate MPF inactivation in
mitotic ones [58–63]. We propose that Cdc55 acts directly
or indirectly to maintain Mih1 activity and to inhibit Swe1
activity in cells with defective spindles, thereby keeping
MPF activity high and arresting cells in mitosis. Lack of
Cdc55 would alter this balance, leading to inhibition of
Mih1, activation of Swe1, inhibitory phosphorylation of
Cdc28, and inactivation of MPF. 
It is also possible that PP2A has a role in reversing the
mitotic phosphorylations effected by MPF or its down-
stream kinases, in addition to its role in regulating MPF
activity. Three lines of evidence support this idea: in vitro,
PP2A dephosphorylates physiological substrates of cyclin-
dependent kinases [42]; the potent PP2A inhibitor okadaic
acid prevents sister chromatid separation in mammalian
cells [64]; and the lack of the Drosophila 55 kDa PP2A B
subunit results in abnormal anaphases [65]. Whether or not
the same is true in S. cerevisiae remains to be seen.
Finally, we would like to know what function Cdc55 has
in exit from the spindle-assembly checkpoint. Exit from
mitosis normally requires cyclin degradation, and non-
degradable cyclins arrest cells in mitosis [4,28]. In the
checkpoint arrest, however, cdc55D cells inactivate MPF
and return to interphase despite the presence of high
levels of B-type cyclins associated with Cdc28. This may
reflect a difference between normal mitotic control and
the control of aberrant mitoses. Exit from the mitotic
checkpoint occurs once the chromosomes have success-
fully attached to the spindle (recovery) [12–14,16]. It has
also been observed that cells that are unable to assemble a
spindle will eventually exit from mitosis, despite presum-
ably never receiving the signal that the mitotic apparatus
has been successfully assembled (adaptation) [66–68]. In
either of these cases, it is possible that rather than revers-
ing the stabilization of B-type cyclins effected by the
spindle assembly checkpoint, cells simply bypass the pro-
teolytic mechanisms and inactivate MPF by phosphorylat-
ing the inhibitory sites on Cdc28.
Conclusions
We conclude that absence of the Cdc55 protein perturbs
PP2A activity in a way that allows MPF to be inactivated by
inhibitory phosphorylation instead of by cyclin destruction.
Preventing the inhibitory phosphorylation of Cdc28 blocks
sister chromatid separation. Thus, in cdc55D cells treated
with nocodazole, sister chromatid separation appears to be
regulated by MPF activity rather than protein degradation. 
Materials and methods
Strains and media
All strains used in this paper were derived from strain AFS34, an iso-
genic derivative of W303a. Gene transplacements and deletions or
disruptions were performed by the one-step gene disruption method
[69]. MAD2 was deleted using a disruption construct that removed the
entire open reading frame (R-H. Chen and A.W.M., unpublished
results). CDC55 was deleted by insertion of the HIS3 gene between
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Figure 8
A model for the control of sister chromatid
separation in budding yeast. Sister separation
is inhibited by Pds1 and the presence of active
MPF. Both of these inhibitory influences are
required to maintain sister linkage. Activation
of the cyclin proteolysis machinery induces the
destruction of cyclin and Pds1, thereby
removing both forms of inhibition and inducing
chromosome separation. MPF can also be
inactivated by inhibitory phosphorylations on
Thr18 and Tyr19 (only the latter is shown). The
tyrosine phosphorylation is due to Swe1,
which is activated by PP2A, whereas Mih1, the
tyrosine phosphatase, is inhibited by PP2A.
Cdc55 reduces the activity of PP2A towards
both of these substrates, thus favoring active
MPF. Finally, we believe that the Mad- and
Bub-dependent part of the spindle-assembly
checkpoint acts to inhibit the activity of the
cyclin-proteolysis machinery in cells with
spindle defects. For some proteins the names
of their fission yeast counterparts are indicated
in parentheses.
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the SpeI site (nucleotide 817) and an end-filled BamHI site nucleotide
1756) as shown in Fig. 1. The SacI–MluI fragment was then used to
transform wild-type W303 and HIS+ transformants were selected.
Transformants were checked for integration of the HIS3 into the
genomic CDC55 gene by the polymerase chain reaction. Mutants of
CDC28 in which Thr18 was replaced by Val and Tyr19 by Phe were
made as described previously [40]. GFP–LacI under the control of the
HIS3 promoter was integrated at the HIS3 locus by integration of
plasmid pAFS78 after NheI digestion [34]. Lac operator repeats [70]
were integrated at the LEU2 locus by integration of plasmid pAFS59
after EcoRV digestion [34]. All cells used were MATa.
Yeast media, a factor, benomyl and hydroxyurea were prepared and
used as described previously [19,21,68]. Nocodazole was purchased
from Sigma, dissolved to 10 mg ml–1 in dimethylsulfoxide and this stock
was diluted 1000-fold into media. All yeast were grown at 23 °C to
ensure consistent effects of microtubule-depolymerizing drugs.
Cloning and sequencing
CDC55 was cloned using a yeast genomic DNA library in YCp50 [21]
to rescue the benomyl sensitivity of JM215 on YPD plates. A 10 kb res-
cuing fragment was restriction mapped and subcloned, and subclones
were tested for their ability to rescue the JM215 benomyl sensitive phe-
notype. The ends of a positive 2.8 kb SacI–MluI fragment in pRS303
were sequenced by the chain termination method [71] using Seque-
nase from USB, following the manufacturers’ directions. The
sequences were compared with sequences in Genbank and found to
be identical with the ends of a 2830 bp SacI–MluI piece of the S. cere-
visiae genome located on chromosome VIII, containing the gene for
CDC55, and an unidentified open reading frame. Restriction mapping
of our subclone with a number of enzymes gave the patterns predicted
by the yeast genomic sequence.
Cell death in nocodazole
The rate of death of strains with depolymerized microtubules were mea-
sured by a modification of the method described in [19], as described
in the legend to Figure 2b.
Western blotting: Clb2 and anti-phosphotyrosine 
Yeast lysates were prepared as previously described [72]. Proteins
were separated by polyacrylamide gel electrophoresis [73] and
immunoblotted for Clb2 and Clb3 using previously described antibod-
ies [74]. Phosphotyrosine was detected by probing the blots with a
rabbit polyclonal antibody from Zymed Laboratories.
Histone H1 kinase assay
Clb2 was immunoprecipitated from yeast lysates and used to phospho-
rylate histone H1 as described previously [72].
Chromosome staining: in situ hybridization and GFP–LacI
Log-phase cultures of strains — AFS173 (wild-type), AFS176 (mad2),
JM480 (cdc55D) and JM477 (cdc55D cdc28-VF) — containing
GFP–LacI under control of the HIS3 promoter and Lac operator repeats
integrated at the LEU2 locus on chromosome 3, were induced for 30 min
in CSM-HIS plus 10 mM 3-aminotriazole. After removal of 3-aminotria-
zole, cells were resuspended in YPD with or without 10mg ml–1 nocoda-
zole. Cultures were fixed for 30 min in 3.7 % formaldehyde and the
GFP–LacI staining was visualized using conventional fluorescence
microscopy. For further details, see [34]. The fraction of cells with sepa-
rated sister chromatids was then calculated for each cell population. 
In situ hybridization was performed to intact, fixed yeast cells after enzy-
matic removal of the cell wall. Cultures were grown to mid log phase,
fixed with paraformaldehyde, spheroplasted with Zymolyase 100-T
(Seikagaku), and the cells adhered to polylysine-coated coverslips. In
these experiments, the probe was a cloned yeast rDNA repeat; the
plasmid was fragmented and 3′-end labeled with Rhodamine-4-dUTP
(FluoroRed, Amersham) using terminal deoxynucleotidyl transferase
(TdT, Promega). Fixation and hybridization to S. cerevisiae cells are
described in greater detail elsewhere [33].
Phosphatase assay
Calf histone H1 (Boehringer Mannheim) was phosphorylated to
3.5 mol phosphate per mol H1 by Xenopus MPF as follows. MPF was
bound to p13suc1 beads and washed as described previously [75,76].
The bead-bound MPF was incubated in 80 mM Na b-glycerophosphate
(pH 7.4), 15 mM MgCl2, 20 mM EGTA, 1 mM ATP (0.8 mCi ml–1), 2
mM DTT, 60 mM histone H1 for 6 h at 30 °C. Histone H1 was sepa-
rated from bead-bound MPF and free label by loading 100 ml aliquots
of the entire phosphorylation reaction onto 1 ml Sepharose G-50 spin
columns equilibrated with 10 mM Tris-Cl (pH 7.4), 1 mM EDTA, 15 mM
2-mercaptoethanol. Yeast lysates were made as described previously
[43]. Lysates were diluted to 0.1 mg ml–1 protein in 50 mM Tris-Cl (pH
7.5), 1 mM EDTA, 15 mM 2-mercaptoethanol, 0.3 mg ml–1 bovine
serum albumin (Boehringer Mannheim), 100 nM inhibitor I2 and, in
some cases, 2 nM okadaic acid [43,77]. Phosphohistone H1 was
added to 5 mM and phosphatase activity was measured by the release
of inorganic phosphate from histone H1 [42].
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